ORIGINAL RESEARCH article
Front. Oncol.
Sec. Thoracic Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1489327
This article is part of the Research TopicRecent Advancements and Developments in Targeted Drug Delivery Systems for Cancer Diagnosis and TherapyView all 6 articles
Second-Line Chemotherapy Rechallenge in Lung Cancer Patients: A Moroccan Real-World Study
Provisionally accepted- 1Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco
- 2Department of Medical Oncology, Mohammed VI University Hospital of Marrakech., Marrakech, Morocco
- 3Medical Oncology Department, Avicenna Military Hospital of Marrakech, Marrakech, Morocco
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
please see the Abstract section in the main manuscript
Keywords: lung cancer, Real world data (RWD), Chemotherapy rechallenge, Moroccan cohort, Second-line
Received: 31 Aug 2024; Accepted: 28 Apr 2025.
Copyright: © 2025 Tafenzi, Choulli, Essaadi and Belbaraka. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hassan Abdelilah Tafenzi, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.